Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 487 of 5804
-
Sound waves vs. pancreatic cancer: new device tested in humans
Disease control Recruiting nowThe purpose of this trial is to evaluate the safety of the HistoSonics Edison System for the destruction of pancreatic adenocarcinomas using histotripsy.
Phase: NA • Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
AI reads your Heart's electrical signals to find hidden blockages
Diagnosis OngoingAI ECG TIMI is an investigator-initiated, international, and multicenter registry of acute coronary syndrome patients aimed to identify electrocardiographic findings detected by an AI model predicting coronary blood flow alteration. The aim of the study is to identify electrocard…
Sponsor: Powerful Medical • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
New algorithm could let kidney patients take less Anti-Rejection meds
Disease control Recruiting nowThe goal of this clinical trial is that validation of the non-invasive biomarkers of the AGORA algorithm should make it possible to select patients with a very low immunological risk of graft failure to authorize safe minimization of their immunosuppression for adult patients at …
Phase: PHASE3 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Blood test may personalize esophageal cancer therapy
Disease control Recruiting nowEsophageal squamous cell carcinoma (ESCC) continues to exhibit high incidence and mortality rates in China, with the majority of patients diagnosed at middle to advanced stages. Concurrent chemoradiotherapy (CCRT) is the standard treatment for unresectable locally advanced ESCC. …
Phase: NA • Sponsor: The Central Hospital of Lishui City • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Mindfulness sleep program aims to stop perinatal depression before it starts
Prevention Recruiting nowPerinatal depression (PND) is the most common complication in pregnancy and postpartum, which increases risk for adverse perinatal outcomes such as preterm birth, maternal suicidal thoughts, and impaired mother-infant bonding. Insomnia often precedes PND cases and may serve as an…
Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Prevention
Last updated Jun 27, 2026 12:09 UTC
-
Custom stents could replace open surgery for deadly aortic bulges
Disease control Recruiting nowThe primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both…
Phase: NA • Sponsor: Bjoern D. Suckow • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for tough prostate cancer: xaluritamig takes on standard therapy in major trial
Disease control OngoingThe main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or second androgen receptor-directed therapy \[ARDT\]).
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
One shot for two threats: new combo vaccine tested in seniors
⭐️ VACCINE ⭐️ CompletedThis is a medical study where participants will be randomly assigned to receive either a new combination vaccine that protects against both COVID-19 and the flu, or a standard flu vaccine. The researchers conducting the study won't know which vaccine each participant receives, en…
Phase: PHASE3 • Sponsor: Novavax • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:03 UTC
-
New shot could slash 'Bad' cholesterol in kids with genetic heart risk
Disease control Recruiting nowThis is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 6 to \<12 years) with heterozygous familial hypercholesterolemia (HeFH) and elevated low density lipoprotein cholesterol (LDLC).
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New obesity pill shows promise in early trial
Disease control CompletedThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07976016) for the potential treatment of obesity. The study will compare the experiences of participants taking the study medicine (PF-07976016) to those of participants w…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New mRNA vaccine targets bird flu pandemic threat
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to evaluate a pandemic flu H5 strain messenger ribonucleic acid (mRNA) vaccine at 3 dose levels (low, medium, and high) in comparison with placebo in 276 healthy adult participants to select the adequate dose for further clinical development. The dur…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
Can a common cholesterol drug boost immunotherapy against head and neck cancer?
Disease control Recruiting nowThis phase II trial tests how well lovastatin and pembrolizumab work in treating patients with head and neck cancer that has come back after a period of improvement (recurrent) or that has spread from where it first started (primary site) to other places in the body (metastatic).…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New heart valve device could help patients with heart pumps avoid open surgery
Disease control OngoingTo evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with continuous flow left ventricular assist devices (cfLVAD) and clinically significant aortic regurgitation (AR) who are indicated…
Phase: NA • Sponsor: JenaValve Technology, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New pill aims to keep High-Risk COVID patients out of the hospital
Disease control Recruiting nowThe purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospital but who are at high risk for progression to severe disease. Eligible participants will be randomly assigned (by chance)…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Scientists hunt for long COVID fingerprints in the brain and blood
Knowledge-focused Recruiting nowCovid-long pathology affects a large number of patients, and represents a major medical, economic and societal challenge. To date, we have no objective criterion for a definitive diagnosis, nor any predictive tool for monitoring the evolution of Covid-long. Based on recruitment f…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New hope for stage III lung cancer? trial adds experimental drug to standard care
Disease control Recruiting nowThe purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation immunotherapy (cIT) can improve objective response rate (ORR; that is percentage of participants whose be…
Phase: PHASE2 • Sponsor: Johnson & Johnson Enterprise Innovation Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo aims to fight tough childhood cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the investigational drug, tipifarnib (a pill taken by mouth), in combination with the Food and Drug Administration (FDA) approved drug, naxitimab, administered intravenously (IV; a liquid that continuously goes into your body through a tub…
Phase: PHASE2 • Sponsor: Giselle Sholler • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New cocktail targets tough leukemia mutations
Disease control Recruiting nowThis research is being conducted to determine a safe and effective dose of revumenib that can be given in combination with standard induction (initial therapy to induce a remission) + FLT3 targeted therapy (midostaurin) and a single cycle of post-remission therapy + FLT3 targeted…
Phase: PHASE1 • Sponsor: Richard Stone, MD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Triple-Drug attack offers hope for Hard-to-Treat colorectal cancer
Disease control Recruiting nowA randomised, open-label, multicenter phase III study to evaluate the efficacy and safety of tucidinostat in combination with sintilimab and bevacizumab versus fruquintinib monotherapy in MSS/pMMR colorectal cancer patients.
Phase: PHASE3 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Light-activated therapy may boost immune attack on hard-to-treat pancreatic cancer
Disease control OngoingThis phase II trial tests how well photoradiation with verteporfin and pembrolizumab plus standard of care chemotherapy works in treating patients with pancreatic cancer that cannot be removed by surgery (unresectable), that has spread to nearby tissue or lymph nodes (locally adv…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC